Acute Care in Cirrhosis the First 24 Hours

Total Page:16

File Type:pdf, Size:1020Kb

Acute Care in Cirrhosis the First 24 Hours Acute Care in Cirrhosis …the first 24 hours Royal College Physicians GIM Training Day, Sheffield March 2018 Rebecca Jones Consultant Hepatologist Chronic Liver Disease • Increasing prevalence of chronic liver disease – Rise in hospital admissions for complications • Decompensated cirrhosis • Acute on chronic liver failure – Large variation in in-hospital mortality rates across UK • E.g Dr Foster – 15% to 35% mortality for non-elective liver admissions – Rising mortality – 3rd commonest cause of premature mortality • Commonest causes are – Alcohol – Obesity – Viral hepatitis – “Liver screen” – remember co-factors exist Liver Disease Mortality Trends Atlas of Variation 2017 Decompensated Cirrhosis • An acute deterioration in liver function in a patient with cirrhosis that can manifest with the following: – jaundice – increasing ascites – hepatic encephalopathy – renal impairment/ hypovolaemia – gastrointestinal (GI) bleeding – signs of sepsis • Overall risk of death during admission with decompensated cirrhosis is 10-20% • If there is organ failure then “acute on chronic liver failure” (ACLF) carries a 30% mortality rate at 28 days. • If alcohol related cirrhosis is diagnosed in hospital, the 1 year mortality is 30% and the 5 year mortality is 60%. Complications of Cirrhosis HRS Ascites SBP Varices Cirrhosis HCC Encephalopathy Osteodystrophy Malnutrition Confused? Scared? What leads to an acute admission? And what causes people to die? Mortality • Patients with cirrhosis die from – Bleeding – Sepsis – Renal Failure • They are admitted with these complications • They develop them during their admission • Their care is often sub-optimal, with delays in appropriate diagnosis, prevention and management of complications of decompensation. 2013 NCEPOD Recommendation • NCEPOD 2013 Measuring the Units – Only 47% of patients who died of alcohol related liver disease received “good” care – Identified avoidable deaths – Recommended a toolkit for acute management of patients admitted with decompensated ARLD • Principles are the same for all causes of decompensated liver disease – Cirrhosis Care Bundle – Effective, evidence based care for first 24hrs How did patients arrive in hospital? 11 Age – wholeAge population 66% (1584/2418) of the ARLD deaths were male 12 Presenting features Complex patient group Risk of death increased if (any of): • Jaundice • Ascites • Encephalopathy • Renal failure • Acute alcoholic hepatitis At least one of these features present in 438/512 patients (85%) 13 Principles of Acute Care • Look for common precipitants and treat accordingly. • These include: – GI bleeding (variceal & non-variceal) – Sepsis (incl. look for SBP, chest, urine, cholangitis) – Alcoholic hepatitis – Portal vein thrombosis – Development of HCC – Drugs – opiates, NSAIDs, alcohol – Ischaemic liver injury (hypotension, any cause) – Dehydration – Constipation • Key words – Look – Treat – Prevent Varices Varices: endoscopy Varices Varices • Varices occur when HVPG is >10 mmHg – Present in ~50 % of cirrhotic patients – Bleeding rate 5-15% per year – Mortality associated with variceal bleed is 20% at 6 weeks • Will present acutely in a variety of ways – Shock – Not shocked – Haematemesis – Malaena – Anaemia • And in a variety of circumstances – Patient known to have varices – Patient known to have cirrhosis – Patient with decompensated liver disease – Patient not known to have cirrhosis/liver disease Varices Varices General management • Manage as for any GI bleed – ABC • Assess appropriate level of care – Transfuse as necessary • Support abnormal clotting or thrombocytopaenia – Request endoscopy • Assess urgency Varices Varices Specific medical management • If varices are known or strongly suspected – Care with transfusion • Aim Hb 8 • Caution in pushing up BP – aim for MAP of 65mmHg • Monitor urine output • Search for cause - AAH, PVT, Infection – Blood products • FFP (2) and platelets (50) – Actively seek out infection • Send blood cultures • CXR, urine, ascitic tap • Treat according to site – Actively prevent infection • Prophylactic antibiotics save lives – sepsis and rebleed risk • Broad spectrum IV – Use splanchnic vasoconstrictors • Terlipressin – 2mg qds • Caution in patients with history of ischaemic heart disease – They may be more shocked than you realise • Are they on beta-blockers? NICE Guideline on GI Bleeding (CG141; 2012) • Risk assessment – Use the following formal risk assessment scores for all patients with acute upper gastrointestinal bleeding: • the Blatchford score at first assessment, and • the full Rockall score after endoscopy. • Timing of endoscopy – Offer endoscopy to unstable patients with severe acute upper gastrointestinal bleeding immediately after resuscitation. – Offer endoscopy within 24 hours of admission to all other patients with upper gastrointestinal bleeding. • Management of variceal bleeding – Offer prophylactic antibiotic therapy at presentation to patients with suspected or confirmed variceal bleeding. – Offer terlipressin to patients with suspected variceal bleeding at presentation. – Stop treatment after definitive haemostasis has been achieved, or after 5 days, unless there is another indication for its use – Band ligation for oesophageal varices; Glue for gastric varices • Consider transjugular intrahepatic portosystemic shunts (TIPS) if bleeding from oesophageal varices is not controlled by band ligation. • Offer TIPS if bleeding from gastric varices is not controlled by endoscopic injection of N-butyl-2-cyanoacrylate. Case study 12 A 32 year old with cirrhosis due to ARLD was admitted midweek in normal working hours with a GI bleed. They were hypothermic, hypotensive, acidotic and in renal failure. They had ascites and encephalopthy. Hb was 6g/dl. They were transfused and actively warmed. No attempt was made to obtain gastroenterology review. They were referred to ICU but denied admission. They remained oliguric, had a further massive haematemesis and had a cardiac arrest and died The Advisors’ view was that more aggressive treatment of the bleed including endoscopy was indicated and that critical care admission was turned down inappropriately 20 Ascites Ascites • Most common complication of cirrhosis • Advancing cirrhosis • Development of portal vein thrombosis • Development of Hepatocellular Carcinoma (HCC) • Prognostic indicator: 50% mortality at 2 years • Spectrum of severity • Grade 1 (radiologically present, not clinically) • Grade 2 (modest, clinically evident) • Grade 3 (large, very distended abdomen) – Uncomplicated • Diuretic controlled • Not infected, no renal failure – Refractory • Diuretic intolerant • Diuretic resistant • Spontaneous Bacterial Peritonitis • Renal failure ?Hepatorenal syndrome Diagnostic paracentesis • Diagnosis of aetiology • Diagnosis of infective complications • Left lower quadrant may be preferable – Abdominal wall is thinner • Complications – Abdominal wall haematoma 1% – Haemoperitoneum/bowel entry Epigastric arteries <0.1% • Aseptic technique Anterior superior iliac crest • Over 70% will have “coagulopathy” 3cm above • Cirrhosis is a pro-coagulant condition 3cm medial – No evidence of increased bleeding rates – No evidence to support routine use of platelets/FFP • BSG guidelines recommend informed consent Runyon B. AASLD Guidelines 2009 Moore K, Aithal G. BSG Guidelines 2006 Interpreting ascitic cell counts • Spontaneous bacterial peritonitis is an important infection to diagnose • Ascitic neutrophil count – 250 cells/cm3 is diagnostic (0.25 x 109/L) – In absence of perforated viscus etc • Ascitic culture from universal containers is not as good as aseptic inoculation into blood culture bottles – 40% vs 80% organism identification – Organisms in SBP usually gram –ve and single • Multiple organisms – think secondary peritonitis • Gram +ve – seen after hospitalisation, instrumentation, antibiotic prophylaxis Interpreting ascitic albumin and protein levels Serum ascites-albumin Ascitic total protein gradient • Very useful to establish group of • Useful to determine risk of causes spontaneous bacterial • SA-AG ≥11g/L peritonitis – Cirrhosis – Ascitic protein is >25g/L in – Cardiac failure 25% patients with cirrhosis – Nephrotic syndrome – SBP uncommon with ascitic protein >15g/L • SA-AG <11g/L – Risk of SBP increased with – Malignancy ascitic protein levels ≤ 10g/L – Tuberculosis – Pancreatitis Ascites Ascites: investigation • Diagnostic tap – This is a mandatory urgent investigation for anyone admitted to hospital with ascites • For first presentations always send for – Cytology – Leucocyte count – Microbiology – Protein • In patients known to have cirrhosis, review previous results. It may not be necessary to repeat cytology if assessed recently but – Leucocyte count – Microbiology • Send ascitic fluid inoculated into blood culture bottles – Protein • Should always be done • And always looked up Ascites Management of ascites • Review medication – Stop NSAIDS • Fluid status – Commence daily weight chart – If no renal impairment, commence diuretics • Usually spironolactone • If lots of peripheral oedema can consider furosemide/bumetanide – If there is renal impairment • Avoid starting diuretics, stop any already prescribed • Infection – If SBP is present • Ensure a sample of ascites has been inoculated into blood culture bottles to get best chance of identifying organism. • Treat with appropriate antibiotics and adjust according to culture results • Treat for 5 days – if concerned about response then repeat tap Ascites Management of ascites • Paracentesis – Consider
Recommended publications
  • Defining and Measuring Quality in Endoscopy
    Communication from the ASGE QUALITY INDICATORS FOR Quality Assurance in Endoscopy Committee GI ENDOSCOPIC PROCEDURES Defining and measuring quality in endoscopy Quality has been a key focus for gastroenterology, The expert panels that were convened in 2005 compiled a driven by a common desire to promote best practices list of quality indicators that were deemed, at the time, to be among gastroenterologists and to foster evidence-based both feasible to measure and associated with improved pa- care for our patients. The movement to define and then tient outcomes. Feasibility concerns precluded measures measure aspects of quality for endoscopy was sparked by that required data collection after the date of endoscopy ser- public demand arising from alarming reports about medi- vice. Accordingly, the majority of the initial indicators con- cal errors. Two landmark articles published in 2000 and sisted of process measures, often related to documentation 2001 led to a national imperative to address perceived of important parameters in the endoscopy note. The evi- areas of underperformance and variations in care across dence demonstrating a link between these indicators to many fields of medicine.1,2 Initial efforts to designate and improved outcomes was limited. In many instances, the require reporting a small number of basic outcome mea- 2005 task force relied on expert opinion. Setting perfor- sures were mandated by the Centers for Medicare & mance targets based on community benchmarks was intro- Medicaid Services, and the process to develop perfor- duced, yet there was significant uncertainty about standard mance measures for government reporting and “pay for levels of performance. Reports citing performance data often performance” programs was initiated.
    [Show full text]
  • Role of Aims65 Score in Determining Frequency of Mortality in Patients with Upper Gastrointestinal Bleed
    Open Access Original Article Role of AIMS65 Score in Upper Gastrointestinal Bleed Pak Armed Forces Med J 2019; 69(2): 245-49 ROLE OF AIMS65 SCORE IN DETERMINING FREQUENCY OF MORTALITY IN PATIENTS WITH UPPER GASTROINTESTINAL BLEED Raja Jibran Akbar, Muhammad Ali Yousaf, Wajjiha Waheed, Manzoor Qadir*, Sajid Ali, Hammad Javaid** Combined Military Hospital Quetta/National University of Medical Sciences (NUMS) Pakistan, *Combined Military Hospital Skardu/ National University of Medical Sciences (NUMS) Pakistan, **Combined Military Hospital Kohat/National University of Medical Sciences (NUMS) Pakistan ABSTRACT Objective: To determine the frequency of mortality in upper gastrointestinal bleed patients having AIMS65 score >3. Study Design: Descriptive case series study. Place and Duration of Study: Department of Accident and Emergency and the Department of Medicine, Combined Military Hospital Quetta, from Sep 2015 to Sep 2016. Material and Methods: All patients having AIMS65 score>3 with UGIB, defined by the presence of hematemesis, melena or hematochezia, and/or a positive N/G tube aspiration for coffee ground, black or bloody contents were enrolled. Information on clinical factors was collected by taking a history and conducting an examination. Blood pressure was recorded manually by mercury sphygmomanometer. Blood samples of patients were collected for serum Albumin and international normalized ratio (INR). Laboratory investigations were sent to hospital laboratory which was headed by classified pathologist. AIMS65 mortality score of UGIB was calculated. Each risk factor (variable) carries one point. Thirty days mortality was calculated in patients with AIMS65 score>3. If the patients had been discharged before the time then outcome was determined through telephone communication. Results: Mean age of the patients was 57.69 ± 16.68 years.
    [Show full text]
  • Accuracy of Rockall Score for in Hospital Re- Bleeding Among Cirrhotic Patients with Vari- Ceal Bleed
    Original Article ACCURACY OF ROCKALL SCORE FOR IN HOSPITAL RE- BLEEDING AMONG CIRRHOTIC PATIENTS WITH VARI- CEAL BLEED Samina Ali Asgher,1 Muhammad Khurram Saleem,2 Amina Hussain 3 Abstract assessed by calculating sensitivity, specificity, positive and negative predictive values using 2 × 2 tables. Objective: To assess the diagnostic accuracy of Roc- Results: In the study, 175 patients were included. kall scoring system for predicting in-hospital re-ble- Mean age was 51.5 ± 1.22 years. Male to female ratio eding in cirrhotic patients presenting with variceal was 1.5 to 1.Out of 175 patients, 157 patients (89.7%) bleed. were of low risk group (score ≤ 2) while 18 patients Material and Methods: This descriptive case series (10.3%) were in high risk group (score ≥ 8). In low study was conducted at Department of Medicine Com- risk group, re-bleeding occurred only in 2 patients bined Military Hospital Lahore from December 2013 (1.2%) while in high risk group, re-bleeding occurred to May 2014. We included patients with liver cirrhosis in 14 patients (78%). Rockall score was found to have who presented with upper GI bleeding and showed good diagnostic accuracy with sensitivity of 87.5%, varices as the cause of bleeding on endoscopy. Clini- specificity of 97.48%, positive predictive value of cal and endoscopic features were noted to calculate 77.8% and negative predictive value of 98.7%. Rockall score. Patients with score of ≤ 2 and ≥ 8 were Conclusion: In cases of variceal bleed, frequency of included. After treating with appropriate pharmacolo- re-bleed is less in patients who are in low risk category gical and endoscopic therapy, patients were followed with lower Rockall score and high in high risk patients for re-bleeding for 10 days.
    [Show full text]
  • Clinical Scoring Systems in Predicting the Outcomes of Small Bowel Bleeding
    32 6 Clinical Scoring Systems Predicting Small Bowel Bleeding ORIGINAL ARTICLE GASTROINTESTINAL TRACT Su et al. Clinical Scoring Systems in Predicting the Outcomes of Small Bowel Bleeding Su Shuai1, Zhang Zhifang2, Wang Yuming1, Jin Hong1, Sun Chao1, Jiang Kui1, Wang Bangmao1 1Department of gastroenterology and hepatology, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China 2Department of Neurology, Tianjin Xiqing Hospital, Tianjin, People’s Republic of China Cite this article as: Su S, Zhang Z, Wang Y, et al. Clinical scoring systems in predicting the outcomes of small bowel bleeding. Turk J Gastroenterol. 2021; 32(6): 493-499. ABSTRACT Background: The aim was to assess the clinical Glasgow–Blatchford score (GBS), Rockall score (CRS), and AIMS65 score in predicting outcomes (rebleeding, need for intervention, and length of stay) among patients with small bowel hemorrhage. Methods: We conducted a retrospective study of patients with small bowel bleeding (SBB). Rebleeding, need for intervention, and length of stay was investigated by 3 scoring systems. The area under the receiver operator characteristic curve was used to analyze the perfor- mance of 3 scoring systems. Results: Among 162 included patients, the scores of rebleeding, intervention, and length of stay ≥10 days groups were higher than no rebleeding, non-intervention, and length of stay <10 days groups, respectively (P < .05). The CRS, GBS, and AIMS65 scoring systems dem- onstrated statistically significant difference in predicting rebleeding (AUROC 0.693 vs. 0.790 vs. 0.740; all P < .01), intervention (AUROC: 0.726 vs. 0.825 vs. 0.773; all P < .01) and length of stay (AUROC 0.651 vs.
    [Show full text]
  • Endoscopic Hemostasis Followed by Preventive Transarterial
    Kaminskis et al. World Journal of Emergency Surgery (2019) 14:45 https://doi.org/10.1186/s13017-019-0264-z RESEARCH ARTICLE Open Access Endoscopic hemostasis followed by preventive transarterial embolization in high-risk patients with bleeding peptic ulcer: 5-year experience Aleksejs Kaminskis1* , Patricija Ivanova1, Aina Kratovska1, Sanita Ponomarjova1, Margarita Ptašņuka2, Jevgenijs Demičevs3, Renate Demičeva3, Viesturs Boka3 and Guntars Pupelis1,2 Abstract Background: Upper gastrointestinal bleeding (UGIB) due to peptic ulcer disease is one of the leading causes of death in patients with non-variceal bleeding, resulting in up to 10% mortality rate, and the patient group at high risk of rebleeding (Forrest IA, IB, and IIA) often requires additional therapy after endoscopic hemostasis. Preventive transarterial embolization (P-TAE) after endoscopic hemostasis was introduced in our institution in 2014. The aim of the study is an assessment of the intermediate results of P-TAE following primary endoscopic hemostasis in patients with serious comorbid conditions and high risk of rebleeding. Methods: During the period from 2014 to 2018, a total of 399 patients referred to our institution with a bleeding peptic ulcer, classified as type Forrest IA, IB, or IIA with the Rockall score ≥ 5, after endoscopic hemostasis was prospectively included in two groups—P-TAE group and control group, where endoscopy alone (EA) was performed. The P-TAE patients underwent flow-reducing left gastric artery or gastroduodenal artery embolization according to the ulcer type. The rebleeding rate, complications, frequency of surgical interventions, transfused packed red blood cells (PRBC), amount of fresh frozen plasma (FFP), and mortality rate were analyzed.
    [Show full text]
  • Prognostic Value of AIMS65 Score in Cirrhotic Patients with Upper Gastrointestinal Bleeding
    Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2014, Article ID 787256, 8 pages http://dx.doi.org/10.1155/2014/787256 Research Article Prognostic Value of AIMS65 Score in Cirrhotic Patients with Upper Gastrointestinal Bleeding Vinaya Gaduputi, Molham Abdulsamad, Hassan Tariq, Ahmed Rafeeq, Naeem Abbas, Kavitha Kumbum, and Sridhar Chilimuri Department of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Avenue, Suite No. 10C, Bronx, NY 10457, USA Correspondence should be addressed to Hassan Tariq; [email protected] Received 5 July 2014; Revised 1 December 2014; Accepted 2 December 2014; Published 22 December 2014 Academic Editor: Spiros D. Ladas Copyright © 2014 Vinaya Gaduputi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. Unlike Rockall scoring system, AIMS65 is based only on clinical and laboratory features. In this study we investigated the correlation between the AIMS65 score and Endoscopic Rockall score, in cirrhotic and noncirrhotic patients. Methods. This is a retrospective study of patients admitted with overt UGIB and undergoing esophagogastroduodenoscopy (EGD). AIMS65 and Rockall scores were calculated at the time of admission. We investigated the correlation between both scores along with stigmata of bleed seen on endoscopy. Results. A total of 1255 patients were studied. 152 patients were cirrhotic while 1103 patients were noncirrhotic. There was significant correlation between AIMS65 and Total Rockall scores in patients of both groups. Therewas significant correlation between AIMS65 score and Endoscopic Rockall score in noncirrhotics but not cirrhotics. AIMS65 scores in both cirrhotic and noncirrhotic groups were significantly higher in patients who died from UGIB than in patients who did not.
    [Show full text]
  • Validity of Rockall Scoring System in Determining In
    Original Article Validity Of Rockall Scoring System In Determining In- Hospital Rebleeding Among Cirrhotic Patients With Acute Esophageal/Gastric Variceal Hemorrhage Using Endoscopy As Gold Standard Maqsood Ahmad, Naeem Afzal, Saeed Akhter, Muhammad Irfan, Zahid Yaseen Hashmie Abstract The rate of rebleeding of esophageal varices remains observation for re-bleed in 10 days. Results: The high after cessation of acute esophageal variceal mean age of patients was 50.99±12.47 years. Out of hemorrhage. Rockall scoring system primarily 87 positive cases on Rockall score, 82 cases were developed for patients with non variceal source of true positive. Out of 89 cases, that were negative, 81 bleeding. Objective: To determine the validity of were true negative. Sensitivity, Specificity and Rockall scoring system in determining in-hospital diagnostic accuracy of Rockall score was found to re-bleeding among cirrhotic patients with acute be 91.1%, 94.1% and 92.6%, respectively. Positive esophageal/gastric variceal haemorrhage using predictive value (PPV) of Rockall score was 94.2% endoscopy as gold standard. The study was and negative predictive values (NPV) was 90.0%. conducted in Allied hospital and Liver Centre Conclusion: The risk scoring system developed by Allied/DHQ Hospitals, Faisalabad. Study Period: Rockall and coworkers is a clinically useful scoring Study was carried out from 28-06-2010 to 27-12- system among cirrhotic patients with acute 2010. Patients and Methods: Total 176 cases were esophageal/gastric variceal haemorrhage. Key include in this study. The subjects were scored using Words: Esophageal varices, Cirrhosis, Rockall Rockall scoring system and placed under scoring system, Bleeding.
    [Show full text]
  • The Treatment of Haematemesis and Upper Gastrointestinal Bleeding in United Kingdom Armed Forces and Other Deployed Units
    J Royal Naval Medical Service 2014, Vol 100.3 308 The treatment of haematemesis and upper gastrointestinal bleeding in United Kingdom Armed Forces and other deployed units Surg Lt R Arr Woodward, Surg Cdr M Khan Abstract Introduction Upper Gastro-intestinal (UGI) bleeding is a significant cause of morbidity worldwide. United Kingdom Armed Forces (UKAFs) are not immune to this condition. There is a substantial body of conflicting evidence regarding initial management and risk stratification. Aim To provide the background knowledge and treatment pathways required to assess and manage a patient adequately during the first 24 hours of an episode of UGI bleeding. Assessment Clinical grading of hypovolaemic shock is inaccurate, but is a broad indicator of severity; the Rockall Score must not be used to assess requirement for intervention. Where laboratory assets are available, the Blatchford score is adequate to assess requirements for intervention. Management The principles of hypotensive resuscitation (target systolic blood pressure 90 mmHg for the first hour) hold true for UGI bleeds. In areas where endoscopy is available within four hours, a restrictive pattern of packed Red Blood Cell (pRBC) transfusion may be beneficial. Despite limited evidence of benefit, Proton Pump Inhibitors (PPIs) should be given routinely in UKAFs. Where available, in cases of variceal and non-variceal UGI Haemorrhage without locally available endoscopy, administration of tranexamic acid and somatostatin or octreotide should be considered. Introduction however, Role One units, in particular Royal Naval or Upper Gastro-intestinal (UGI) bleeding is one of the most light infantry units, often operate outside of effective common causes of admission to hospital in the United local medical care.
    [Show full text]
  • (BSG)- Led Multisociety Consensus Care Bundle for the Early Clinical
    GUIDELINES British Society of Gastroenterology (BSG)- led multisociety consensus care bundle for the early clinical management of acute upper gastrointestinal bleeding Keith Siau ,1,2,3 Sarah Hearnshaw,4 Adrian J Stanley,5 Lise Estcourt,6 Ashraf Rasheed,7,8 Andrew Walden,9,10 Mo Thoufeeq,11 Mhairi Donnelly,5 Russell Drummond,5 Andrew M Veitch,12 Sauid Ishaq,3,13 Allan John Morris5,14 For numbered affiliations see end ABSTRACT evidence- based interventions and drive quality of article. Medical care bundles improve standards of improvement and patient outcomes in AUGIB. Correspondence to care and patient outcomes. Acute upper Dr Allan John Morris, Glasgow gastrointestinal bleeding (AUGIB) is a common Royal Infirmary, Glasgow G4 0SF, medical emergency which has been consistently INTRODUCTION UK; john. morris@ ggc. scot. nhs. uk Acute upper gastrointestinal bleeding associated with suboptimal care. We aimed to (AUGIB) is a common medical emer- British Society of develop a multisociety care bundle centred on gency in the UK with an estimated inci- Gastroenterology Conference the early management of AUGIB. 2019 dence of 134 per 100 000 population,1 Commissioned by the British Society of roughly equating to one presentation Gastroenterology (BSG), a UK multisociety task every 6 min. Mortality following AUGIB force was assembled to produce an evidence- over the last two decades has remained based and consensus- based care bundle detailing high at approximately 10%,2 with several key interventions to be performed within UK- wide audits revealing poor stand- 24 hours of presentation with AUGIB. A modified ards of care.2 3 Multiple guidelines have Delphi process was conducted with stakeholder been developed in an attempt to define representation from BSG, Association of Upper quality standards in AUGIB and improve Gastrointestinal Surgeons, Society for Acute patient outcomes.4–6 These unanimously Medicine and the National Blood Transfusion acknowledge the importance of timely Service of the UK.
    [Show full text]
  • 7Th International Advanced Endoscopy Workshop Annual
    Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology Incorporating the 7th International Advanced Endoscopy Workshop 29 August – 1 September 2007 Kota Kinabalu, Sabah, Malaysia Malaysian Society of Gastroenterology and Hepatology CONTENTS LECTURES L1 Milestones In Therapeutic Endoscopy – A Personal Journey 1 N Soehendra L3 The 4th Panir Chelvam Memorial Lecture 2 Evidence Based Medicine In The Real World R H Hunt L5 Screening And Surveillance For Colorectal Cancer: Rationale And 3 Recommendations F A Macrae SYMPOSIA S1 CHRONIC VIRAL HEPATITIS Does Treatment Alter The Natural History Of Disease? – A Critical Look • Does Treatment Alter The Natural History Of Chronic Viral 4 B Hepatitis? – A Critical Perspective M Silva • Does Treatment Alter The Natural History Of Chronic 5 Hepatitis C Disease? C E Millson S2 GASTRIC CANCER • Identifying High-Risk Groups For Gastric Cancer 6 R H Hunt • Improving Outcomes And Treatment For Gastric Cancer 7 K G Yeoh YOUNG INVESTIGATOR’S FREE PAPER SESSION YIA 01 The Correlation Between Non-Invasive Markers And Fibrotic Index 8 On Liver Histology M Z Faizal1, M N Razul1, M Radzi1, N Raihan2, B P Ooi1 1Department of Medicine, 2Department of Pathology, Hospital Alor Setar, Alor Setar, Kedah, Malaysia YIA 02 Randomized Comparison Between Adrenaline Injection Alone 9 And Adrenaline Injection Combined With Monopolar Electrocoagulation In The Treatment Of Acute Bleeding Peptic Ulcer J Rokayah, J Shukri, A R Hashimah Sarawak General Hospital, Kuching, Sarawak, Malaysia GUT 2007 i
    [Show full text]
  • Acute Upper Gastrointestinal Bleeding
    NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY STANDARDS PROGRAMME Quality standard topic: Acute upper gastrointestinal bleeding Output: Briefing paper Introduction This briefing paper presents a structured evidence review to help determine the suitability of recommendations from the key development sources listed below, to be developed into a NICE quality standard. The draft quality statements and measures presented in this paper are based on published recommendations from these key development sources: Gastrointestinal bleeding: the management of acute upper gastrointestinal bleeding. NICE clinical guideline 141 (2012; NICE accredited). Available from www.nice.org.uk/guidance/CG141 Structure of the briefing paper The body of the paper presents supporting evidence for the draft quality standard reviewed against the three dimensions of quality: clinical effectiveness, patient experience and safety. Information is also provided on available cost-effectiveness evidence and current clinical practice for the proposed standard. Where possible, evidence from the clinical guideline is presented. When this is not available, other evidence sources have been used. Quality standard topic: Acute upper gastrointestinal bleeding 1 of 43 NICE QS Topic Expert Group Briefing Paper 1 Risk assessment 1.1 NICE CG141 Recommendations 1.1.1 [KPI] and 1.1.2 1.1.1 Relevant NICE clinical guideline recommendations and proposed quality statement Guideline 1.1.1 Use the following formal risk assessment scores for all recommendations patients with acute
    [Show full text]
  • Clinical Utility of Risk Scores in Variceal Bleeding
    AG-2019-53 AHEADORIGINAL OF ARTICLEPRINT dx.doi.org/10.1590/S0004-2803.201900000-54 Clinical utility of risk scores in variceal bleeding Sanjay CHANDNANI, Pravin RATHI, Suhas Sudhakarrao UDGIRKAR, Nikhil SONTHALIA, Qais CONTRACTOR and Samit JAIN Received 22/3/2019 Accepted 17/6/2019 ABSTRACT – Background – Variceal bleeding remains important cause of upper gastrointestinal bleed. Various risk scores are used in risk stratification for non-variceal bleed. Their utility in variceal bleeding patients is not clear. Objective – This study aims to compare probability of these scores in predicting various outcomes in same population. To study characteristics and validate AIMS65, Rockall, Glasgow Blatchford score(GBS), Progetto Nazionale Emorragia Digestiva (PNED) score in variceal Upper Gastrointestinal Bleed (UGIB) patients for predicting various outcomes in our pop- ulation. Methods – Three hundred subjects with UGIB were screened prospectively. Of these 141 patients with variceal bleeding were assessed with clinical, blood investigations and endoscopy and risk scores were calculated and compared to non-variceal cases. All cases were followed up for 30 days for mortality, rebleeding, requirement of blood transfusion and need of radiological or surgical intervention. Results – Variceal bleeding (141) was more common than non variceal (134) and 25 had negative endoscopy. In variceal group, cirrhosis (85%) was most common etiology. Distribu- tion of age and sex were similar in both groups. Presence of coffee coloured vomitus (P=0.002), painless bleed (P=0.001), edema (P=0.001), ascites (P=0.001), hemoglobin <7.5 gms (P<0.001), pH<7.35 (P<0.001), serum bicarbonate level <17.6 mmol/L (P<0.001), serum albumin<2.75 gms% (P<0.001), platelet count <1.2 lacs/µL (P<0.001), high INR 1.35 (P<0.001), BUN >25mmol/L (P<0.001), and ASA status (P<0.001), high lactate >2.85 mmol/L (P=0.001) were significant.
    [Show full text]